Stockreport

Achilles Therapeutics Reports Third Quarter 2024 Financial Results

Achilles Therapeutics plc - American Depositary Shares  (ACHL) 
PDF – Cash position of $86.1 million as of September 30, 2024, not including cash R&D tax credit of $12.8 million received in October 2024 –         LONDON, Nov. 14, 2024 [Read more]